Pharmaceutical

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

In Canada pharmaceutical industry, there were two private equity deals announced in Q3 2024, worth a total value of $4.2m, according to GlobalData's Deals Database.

Nov 9, 2024 - 06:00
In Canada pharmaceutical industry, there were two private equity deals announced in Q3 2024, worth a total value of $4.2m, according to GlobalData's Deals Database.
Read the original article

Tags:

Previous Article

Santen, Arctic Vision sign deal for ARVN001 to treat UME

Next Article

Improving life science R&D outcomes with AI

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Amgen enlists TScan’s target discovery platform for Crohn’s disease

Amgen enlists TScan’s target discovery platform for Cro...

May 10, 2023

Boehringer and 3T Biosciences partner to develop cancer immunotherapies

Boehringer and 3T Biosciences partner to develop cancer...

Jan 5, 2024

STAT+: Johnson & Johnson is getting rid of its script logo after more than 130 years

STAT+: Johnson & Johnson is getting rid of its script l...

Sep 18, 2023